Milan, Italy - Promising 6-month results of one of the first clinical studies of a drug-eluting stent for in-stent restenosis (ISR) were not maintained at 12 months and carry an important message for ...
For coronary in-stent restenosis (ISR), drug-coated balloons (DCB) appear to perform just as well over the long term as thin-strut drug-eluting stents after accounting for differences in patient ...
Employing drug-eluting balloons (DEBs) to treat in-stent restenosis in the femoropopliteal artery reduces the risk of recurrent restenosis and repeat intervention at 1 year compared with standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback